Fig. 5.
Effect of Akt/mTOR activators on p62 levels in podocytes. A: Western blot analysis of sc-79 on p-Akt (Ser473) and total Akt protein levels for 48 h (n = 3 in each group). B: Western blot analysis of sc-79 and PRR siRNA on p62 protein levels for 48 h (n = 4 in each group). C: Western blot analysis of MHY-1485 on p-mTOR (Ser2448) and total mTOR protein levels for 48 h (n = 3 in each group). D: Western blot analysis of MHY-1485 and PRR siRNA on p62 protein levels for 48 h (n = 3 in each group). Data are presented as means ± SE. *P < 0.05 vs. NG.